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CorrelaSon between radiologic and funcSonal status in Cystic 
Fibrosis (CF) 
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Background: High resolution CT (HRCT) is helpful in the diagnosis, monitoring 
and qualitative description of all detectable lesions of CF. HRfiq" scoring systems 
have been correlated with disease severity as determined by clinical and pulmonary 
function tests (PFl's) and can detect regional lung disease before changes are seen 
ha global PFl's. There are few studies in older CF patients. 
Purpose: To correlate the quantitative HRfiq" score with pulmonary function ha 
adolescents and adults with stable CE 
Mettu)ds: Twenty one stable CF patients (10M, 11F, aged 20+6) were consecutively 
enrolled. They tmderwent PFTs ( lung volumes, f low rates and diffusing capacity), 
arterial blood gases evaluation and 6 min walking test (6M~VT). An  inspiratot3, 
HR fiq" scan (1 mm every 10 ram) was obtained. A modified Bhalla's scoring system 
was used to evaluate elements of bronchial airway (br onchiect asis, mucus plugging, 
sacculation/abscess, peribrcehial  thickening) mad lung parenchymal (bullae, 
emphysema, collapse and consolidation) abnormalities. 
Results: Although subjects tudied were mostly young adults, their lung disease was 
mild to moderate (FVC 81+25 %pr, FEV 1 70+26 %pr and FEF 9~75 49+35 %pr). 
Total HRCT score was 10, 3+4,6. Predominant scoring elements were the extent, 
peripheral ocation and severity of bronchiectasis. HRfiq" score was highly 
correlated with flow rates (FEVI% and FEFg~ 75%, PEF pr %), DLCO %, TLC%, 
6MWT (p<0.CO1), but no correlation was found with arterial blood gases and 
exercise desaturation. 
Conclusions: HRCT score cotlelates with flows and DLCO disturbances ha 
adolescent and adult CF patients. 
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Chest CT in CF paSents with acute chest pain 
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Acute chest pain is a common symptom in patients with CF. We evaluated chest fief 
and its ability ha determining the cause of pain. Chest CT was performed ha adult 
patients with acute chest pain and evaluated for the presence of four features 
including consolidation (with abutment to the pleura), pneumothor ax, effusion, and 
rib fracture. Chest CT performed ha adult CF patients for alternate indications (e.g. 
hemoptysis) were used for comparison. The CT reviewer was blinded to the 
indication for the study. 
A total of 38 studies were performed ha 23 patients. Acute chest pain was the 
indication for 15 studies (n 12 patients). A notable f inding that could account for 
the chest pain was described in 4 of 12 patients (33%) and ha 7 of 15 studies (47%). 
However, a notable f inding was described in the non pain group in 8 of 15 patients 
(53%) and ha 9 of 23 studies (39%). In neither comparison (by patients or studies) 
was there statistical significance. 
Most commonly, the pain c¢curred on the right, anteriorly, and ha the upper lung 
zones. We looked at whether the CT scan findings were able to accurately localize 
the site of the pain. In the 7 patients in whom findings were described, the 
localization was accurate in 5 patients and incorrect in 2 patients. 
There were no significant differences between the groups for mean age and CF 
radiological score. Patients with chest pain had a lower mean BMI  (p 0.05), FVC 
% predicted (p 0.03), and FEV1% predicted (p~).04). 
In conclusion, acute chest pain is a common presenting symptom in adults with CF, 
and seems to occur ha patients with more severe disease. CT chest can reveal 
important f indings that are not detected by standard CXR, some which may result 
in intervention, but it cannot reliably define the tiology or location of acute chest 
pain in adults with CF. 
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CorrelaSon among Cystic Fibrosis (CF) severity markers 
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Aim: To verify the relationship among the available CF severity markers: 
Schwaschman score (SS); Balha Score (BS); Nutr i t ional  Status (NS) and 
Pulmonary Function Tests (PFI'). 
Mettu)ds: Prospective study (2CO1 04) performed at the State University of 
Campinas, Medical  School, Unicamp, Brazil .  The analyzed CF severity variables 
included SS, BS, NS and PFZ Weigh mad height were assessed by Z score ha 65 
patients. 
Results: 76 patients were studied (RN 22years). 39 females. Mean age: 9.5 years 
and a median of 8.2 years. White race: 93.6%. Delta F 508 was present in 83/152 
(54.6%) of the analyzed cbromosomes. SS was obtained in 73/76 patients: 
(excellent/good: 46.58%, moderate 31.5% and severe 21.92%). BS was performed 
ha 64~6 CF patients: 15.9+4.66 medium score. The most frequent computer 
tomography abnormalities were peribronquial wal l  thickening: 96.9%; mucous 
plugging: 84.4%; br onchiectasis: 75%; mosaic per fusion: 48.4%. 
Nutrit ional Status: Normal in 13.3%. Malnutrit ion: 86.7%. Major: (Z< 2): 35.4%; 
Mild: (0< ZP > 1) 13.8%. Short stature (ZA < 2) 21.5% 
PFT was performed in 38 patients older than 7 years. Normal  PFT was obtained ha 
23.68% of the CF patients. Obstructive ventilatory defect: 42.11%; restrictive 
ventilat ory defect 7.9% and obstructive plus restrictive ventilator3, defect: 26.32%. 
A highly significant statistic correlation was observed between SE versus BE 
(p<0.01); SE versus PFT (p<0.01); BE  vers~as PFT (p<0.01); Nutrit ional Status 
versus PFT (p<0.05). BE  versus Nutrit ional Score: Not significant 
Conclusion: Al l  the analyzed markers showed to be a good value ha predicting the 
severity of the cystic fibrosis patients. 
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Colistin dry powder inhalation in cystic fibrosis: novel Twince# 
inhaler compared to nebulizaSon: a pilot study 
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Aim: To assess the feasibility, tolerability and potential cl inical use of colistin &5' 
powder inhalation (DPI) ha CF patients, using the Twincer ®hahaler 
Methods: Ten CF patients participated in a randomized cross over study with 25 mg 
colistin as DPI and 160 mg colistin as nebulized solution. F£V1 and FVC were 
registered before mad after inhalation. Colistin lung deposition was indirectly 
determined by measuring colistin serum concentrations and pharmacokinetic 
analysis. The paired t test was used for statistical analysis. The patient's experience 
was dccumented using a questionnaire. 
Results." Colistin DPI was wel l  tolerated. Post inhalation lung function tests 
indicated no bronchcconstriction. Some patients, famil iar with bronchcconstriction 
after liquid nebulization of colis'tin, experienced no bronchcconstriction r chest 
tightness after DPI. A large variation in systemic bioavailabil ity was observed. 
Serum concentrations and AUC after colistin DPI were lower than expected, despite 
a calculated ose equivalent to l iquid nebulization. 
Lung deposition after DPI tended to be more fficient compared to nebulization. 
The inhaler was wel l  received by the patients. 
Conclusions: Colistin DPI, using the Twincer ® inhaler, can be of clinical use ha 
treatment of CF patients. An  improvement ha compliance is to be expected. The 
optimal dose of colistin by inhalation is not known; a study with an increased 
colistin dry powder dose is mandatory to investigate long term effects in a large CF 
population. 
Furthermore, the Twincer ® inhaler might be suitable for inhalation of other drags. 
